iHuman Inc. (IH) intrinsic value & 10-year financials
iHuman Inc. (IH) has a Graham intrinsic value of $0.01 per share. Over the last 9 fiscal years revenue grew 29.5% a year to $807.0M, with an average return on invested capital of 25.8%.
- Graham intrinsic value
- $0.01
- Revenue (FY2025)
- $807.0M
- Revenue growth (9-yr CAGR)
- 29.5%
- ROIC (10-yr avg)
- 25.8%
- Free cash flow (FY2025)
- $46.4M
IH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $807.0M | $95.4M | $0.36 | $46.4M | 8.3% | -42.0% |
| FY2024 | $922.2M | $98.6M | $0.36 | $51.1M | 7.8% | -31.6% |
| FY2023 | $1.0B | $180.9M | $0.66 | $165.6M | 15.7% | -53.7% |
| FY2022 | $985.5M | $109.8M | $0.41 | $181.9M | 11.3% | -35.8% |
| FY2021 | $944.7M | -$37.1M | -$0.14 | $5.9M | -5.7% | 23.9% |
| FY2020 | $531.9M | -$37.5M | -$0.21 | $207.1M | -8.4% | 20.8% |
| FY2019 | $218.7M | -$275.6M | -$1.52 | $40.2M | -127.5% | 280.2% |
| FY2018 | $131.9M | -$17.6M | — | -$5.0M | -16.7% | 44.6% |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
iHuman Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
iHuman Inc. has historically struggled to out-earn its cost of capital, averaging just -19.7% ROIC.
iHuman Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, iHuman Inc. is modeled at -4.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.01 per share.